Literature DB >> 23791224

Cutaneous Cryptococcus laurentii infection in an immunocompetent child.

Alejandro Molina-Leyva1, Jose C Ruiz-Carrascosa, Ana Leyva-Garcia, Husein Husein-Elahmed.   

Abstract

Cryptococcus laurentii is an extremely rare human pathogen. We report a case of primary cutaneous cryptococcosis caused by Cryptococcus laurentii in an immunocompetent patient, an 8-year-old child with a solitary lesion on the forearm. It was impossible to determine the source of infection and no predisposing factors were found. Oral treatment with fluconazole was totally successful. A review of the literature showed only three cases of cutaneous infection by Cryptococcus laurentii. All of the cases occurred in immunocompromised patients. To the best of our knowledge, this is the first case of Cryptococcus laurentii in an immunocompetent host.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antifungal agents; Case reports; Cryptococcosis drug therapy; Cryptococcosis microbiology; Cryptococcus isolation and purification; Dermatomycoses drug therapy; Dermatomycoses microbiology; Immunocompetence

Mesh:

Substances:

Year:  2013        PMID: 23791224     DOI: 10.1016/j.ijid.2013.04.017

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  11 in total

Review 1.  Systemic Review of Published Reports on Primary Cutaneous Cryptococcosis in Immunocompetent Patients.

Authors:  Lin Du; Yali Yang; Julin Gu; Jianghan Chen; Wanqing Liao; Yuanjie Zhu
Journal:  Mycopathologia       Date:  2015-03-04       Impact factor: 2.574

Review 2.  Fatal primary cutaneous cryptococcosis: case report and review of published literature.

Authors:  Y Liu; H Qunpeng; X Shutian; X Honglang
Journal:  Ir J Med Sci       Date:  2015-08-06       Impact factor: 1.568

3.  Primary cutaneous cryptococcosis treated with debridement and fluconazole monotherapy in an immunosuppressed patient: a case report and review of the literature.

Authors:  Jennifer Wang; Luther Bartelt; Deborah Yu; Anjali Joshi; Bradley Weinbaum; Tiffany Pierson; Michael Patrizio; Cirle A Warren; Molly A Hughes; Gerald Donowitz
Journal:  Case Rep Infect Dis       Date:  2015-02-02

4.  Cryptococcus laurentii Diarrhea in a Neoplastic Patient.

Authors:  Franco Calista; Federica Tomei; Pasquale Assalone; Divina Traficante; Gianni Di Pilla; Carla Pepe; Liberato Di Lullo
Journal:  Case Rep Oncol Med       Date:  2015-01-27

Review 5.  Perspectives on non-neoformans cryptococcal opportunistic infections.

Authors:  Nichole Smith; Matthew Sehring; Jefferson Chambers; Preeti Patel
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-09-19

Review 6.  Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.

Authors:  Yongxi Zhang; Brian Cooper; Xi'en Gui; Renslow Sherer; Qian Cao
Journal:  BMC Infect Dis       Date:  2019-11-27       Impact factor: 3.090

Review 7.  Anti-Fungal Efficacy and Mechanisms of Flavonoids.

Authors:  Mohammed Saleh Al Aboody; Suresh Mickymaray
Journal:  Antibiotics (Basel)       Date:  2020-01-26

8.  First case report of Cryptococcus laurentii knee infection in a previously healthy patient.

Authors:  Hetao Huang; Jianke Pan; Weiyi Yang; Jiongtong Lin; Yanhong Han; Kai Lan; Lingfeng Zeng; Guihong Liang; Jun Liu
Journal:  BMC Infect Dis       Date:  2020-09-17       Impact factor: 3.090

9.  Cryptococcus Species Other Than Cryptococcus neoformans and Cryptococcus gattii: Are They Clinically Significant?

Authors:  Edison J Cano; Zachary A Yetmar; Raymund R Razonable
Journal:  Open Forum Infect Dis       Date:  2020-10-29       Impact factor: 3.835

10.  Two subspecies of bent-winged bats (Miniopterus orianae bassanii and oceanensis) in southern Australia have diverse fungal skin flora but not Pseudogymnoascus destructans.

Authors:  Peter H Holz; Linda F Lumsden; Marc S Marenda; Glenn F Browning; Jasmin Hufschmid
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.